Failure of a 1‐day high‐dose quadruple therapy for cure of Helicobacter pylori infection
Authors:
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (2) , 173-177
Abstract
Background: The optimal duration of treatment for eradication of Helicobacter pylori has still to be defined. A 1‐day high‐dose quadruple therapy with a combination of amoxycillin (or tetracycline), metronidazole, a bismuth salt and a proton pump inhibitor has led to eradication rates of 57–77%. In view of the high frequency of metronidazole‐resistant strains of H. pylori in Europe, we hypothesized that by using clarithromycin in place of metronidazole and by increasing the dose of proton pump inhibitor, the efficacy of a 1‐day high‐dose quadruple therapy could be improved.Methods: Patients were randomized to receive either amoxycillin 1000 mg b.d., clarithromycin 500 mg b.d. and lansoprazole 30 mg b.d. for 7 days, or amoxycillin 2000 mg q.d.s., clarithromycin 500 mg q.d.s., lansoprazole 30 mg t.d.s. and bismuth subcitrate 240 mg q.d.s. for 1 day.Results: It was originally intended to include 100 patients. The first planned interim analysis performed after follow‐up was completed for 30 patients revealed H. pylori eradication rates of 80% (12/15) in the 7‐day triple therapy group and 20% (3/15) in the 1‐day quadruple therapy group, the difference being highly significant (P = 0.003). Because the efficacy of the 1‐day treatment was so low, the study was stopped for ethical reasons. Eleven patients who failed with the 1‐day treatment were re‐treated with the 7‐day triple therapy: the eradication rate was 91% (10/11).Conclusions: One‐day high‐dose quadruple therapy with amoxycillin, clarithromycin, lansoprazole and bismuth subcitrate is dramatically less effective than the classic 7‐day triple therapy with the same antibiotics.Keywords
This publication has 19 references indexed in Scilit:
- One‐day intensified lansoprazole‐quadruple therapy for cure of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1997
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juiceGastroenterology, 1996
- Advantages and Disadvantages of Current Diagnostic Tests for the Detection ofHelicobacter pyloriScandinavian Journal of Gastroenterology, 1996
- Comparison of 4 diagnostic methods for Helicobacter pylori infection: A multicenter study using centralised facilitiesGastroenterology, 1995
- Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trialThe Lancet, 1994
- Impact of Metronidazole Resistance on the Eradication of Helicobacter pyloriScandinavian Journal of Infectious Diseases, 1994
- One-day therapy for treatment ofHelicobacter pylori infectionDigestive Diseases and Sciences, 1993
- Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistanceAlimentary Pharmacology & Therapeutics, 1992
- Disappearance of Gastritis after Eradication ofHelicobacter pylori: A Morphometric StudyScandinavian Journal of Gastroenterology, 1991